论文部分内容阅读
目的观察长春西汀注射液治疗椎基底动脉系统供血不足的疗效。方法入选病例120例均经TCD证实为椎基底动脉系统供血不足[1],患者随机分为两组:治疗组60例,对照组60例。治疗组应用长春西汀20mg加入0.9%氯化钠注射液250ml静脉滴注,1次/d,连用14d;对照组应用灯盏花素注射液50mg加入0.9%氯化钠注射液250ml静脉滴注,1次/d,连用14d。两组中对合并高血压、糖尿病、高脂血症的患者均给予相应的干预治疗。结果治疗组总有效率92.1%,对照组总有效率76.8%。结论长春西汀注射液治疗椎基底动脉系统供血不足疗效肯定,值得临床推广。
Objective To observe the efficacy of vinpocetine injection in the treatment of vertebrobasilar insufficiency. Methods Totally 120 cases were confirmed by TCD as vertebrobasilar insufficiency [1]. The patients were randomly divided into two groups: 60 cases in the treatment group and 60 cases in the control group. Treatment group, vinpocetine 20mg 0.9% sodium chloride injection 250ml intravenous infusion, once / d, once every 14d; the control group using breviscapine injection 50mg 0.9% sodium chloride injection 250ml intravenous drip, 1 time / d, once every 14d. Two groups of patients with hypertension, diabetes, hyperlipidemia were given the appropriate intervention. Results The total effective rate was 92.1% in the treatment group and 76.8% in the control group. Conclusion Vinpocetine injection is effective in treating vertebrobasilar insufficiency and is worthy of clinical promotion.